Co-development Deals in Pharmaceuticals and Biotechnology provides a detailed understanding and analysis of how and why companies enter co-development deals.
Fully revised and updated, the report provides details of co-development deals from 2016 to 2024.
The report provides access to co-development deal payment terms as announced between the parties. This data provides useful insight into the payment and other deal terms.
Understanding the flexibility of a prospective partner’s negotiated deals terms provides critical insight into the negotiation process in terms of what you can expect to achieve during the negotiation of terms. Whilst many smaller companies will be seeking details of the payments clauses, the devil is in the detail in terms of how payments are triggered and rights transferred - contract documents provide this insight where press releases and databases do not.
This report contains a comprehensive listing of co-development deals announced since 2016 as recorded in the Current Agreements deals and alliances database, including financial terms where available, plus links to online copies of actual co-development contract documents as submitted to the Securities Exchange Commission by companies and their partners.
The initial chapters of this report provide an orientation of co-development dealmaking and business activities.
Chapter 1 provides an introduction to the report, whilst chapter 2 provides an overview and analysis of the trends in co-development as well as a discussion on the merits of the type of deal.
Chapter 3 provides an overview of the structure of co-development deals.
Chapter 4 provides a review of the leading co-development deals since 2016. Deals are listed by headline value. Where the deal has an agreement contract published at the SEC a link provides online access to the contract via the Current Agreements deals and alliances database.
Chapter 5 provides a comprehensive listing of the top 25 most active co-development dealmaker companies. Each deal title links via Current Agreements deals and alliances database to an online version of the full deal record, and where available, the actual contract document, providing easy access to each deal record on demand.
Chapter 6 provides a comprehensive and detailed review of co-development deals organized by company A-Z, therapy, technology and industry type signed and announced since 2016 where a contract document is available. Contract documents provide an indepth insight into the actual deal terms agreed between the parties with respect to the co-development deal.
The deal directory includes a comprehensive listing of all co-development deals announced since 2016. Each listing is organized as a deal directory by company A-Z, therapeutic area and technology type. Each deal title links via hyperlink to an online version of the deal record including, where available, the actual contract document.
The report also includes numerous table and figures that illustrate the trends and activities in co-development dealmaking since 2016.
In conclusion, this report provides everything a prospective dealmaker needs to know about co-development alliances.
Co-development Deals in Pharmaceuticals and Biotechnology provides comprehensive access to available records for co-development deals, including contract documents where available.
Fully revised and updated, the report provides details of co-development deals from 2016 to 2024.
The report provides access to co-development deal payment terms as announced between the parties. This data provides useful insight into the payment and other deal terms.
Understanding the flexibility of a prospective partner’s negotiated deals terms provides critical insight into the negotiation process in terms of what you can expect to achieve during the negotiation of terms. Whilst many smaller companies will be seeking details of the payments clauses, the devil is in the detail in terms of how payments are triggered and rights transferred - contract documents provide this insight where press releases and databases do not.
This report contains a comprehensive listing of co-development deals announced since 2016 as recorded in the Current Agreements deals and alliances database, including financial terms where available, plus links to online copies of actual co-development contract documents as submitted to the Securities Exchange Commission by companies and their partners.
The initial chapters of this report provide an orientation of co-development dealmaking and business activities.
Chapter 1 provides an introduction to the report, whilst chapter 2 provides an overview and analysis of the trends in co-development as well as a discussion on the merits of the type of deal.
Chapter 3 provides an overview of the structure of co-development deals.
Chapter 4 provides a review of the leading co-development deals since 2016. Deals are listed by headline value. Where the deal has an agreement contract published at the SEC a link provides online access to the contract via the Current Agreements deals and alliances database.
Chapter 5 provides a comprehensive listing of the top 25 most active co-development dealmaker companies. Each deal title links via Current Agreements deals and alliances database to an online version of the full deal record, and where available, the actual contract document, providing easy access to each deal record on demand.
Chapter 6 provides a comprehensive and detailed review of co-development deals organized by company A-Z, therapy, technology and industry type signed and announced since 2016 where a contract document is available. Contract documents provide an indepth insight into the actual deal terms agreed between the parties with respect to the co-development deal.
The deal directory includes a comprehensive listing of all co-development deals announced since 2016. Each listing is organized as a deal directory by company A-Z, therapeutic area and technology type. Each deal title links via hyperlink to an online version of the deal record including, where available, the actual contract document.
The report also includes numerous table and figures that illustrate the trends and activities in co-development dealmaking since 2016.
In conclusion, this report provides everything a prospective dealmaker needs to know about co-development alliances.
Co-development Deals in Pharmaceuticals and Biotechnology provides the reader with the following key benefits:
- Understand deal trends since 2016
- Browse co-development deals
- Benchmark analysis - identify market value of transactions
- Financials terms
- Directory of deals by company A-Z, therapy focus and technology type
- Leading deals by value
- Most active dealmakers
- Identify assets and deal terms for each transaction
- Access contract documents - insights into deal structures
- Due diligence - assess suitability of your proposed deal terms for partner companies
- Save hundreds of hours of research time
Report Scope
Co-development Deals in Pharmaceuticals and Biotechnology is intended to provide the reader with an in-depth understanding of the co-development trends and structure of deals entered into by leading biopharma companies worldwide.Co-development Deals in Pharmaceuticals and Biotechnology includes:
- Trends in co-development dealmaking in the biopharma industry
- Overview of co-development deal structure
- Directory of co-development deal records covering pharmaceutical and biotechnology
- The leading co-development deals by value
- Most active co-development dealmakers
- The leading co-development partnering resources
In Co-development Deals in Pharmaceuticals and Biotechnology, the available deals are listed by:
- Company A-Z
- Headline value
- Therapeutic area
- Technology type
Co-development Deals in Pharmaceuticals and Biotechnology provides comprehensive access to available records for co-development deals, including contract documents where available.
Analyzing contract agreements allows due diligence of:
- What are the rights granted or optioned?
- What rights are granted by the agreement?
- What exclusivity is granted?
- What is the payment structure for the deal?
- How are sales and payments audited?
- What is the deal term?
- How are the key terms of the agreement defined?
- How are intellectual property rights handled and owned?
- Who is responsible for commercialization?
- Who is responsible for development, supply, and manufacture?
- How is confidentiality and publication managed?
- How are disputes resolved?
- Under what conditions can the deal be terminated?
- What happens when there is a change of ownership?
- What sublicensing and subcontracting provisions have been agreed?
- Which boilerplate clauses does the company insist upon?
- Which boilerplate clauses appear to differ from partner to partner or deal type to deal type?
- Which jurisdiction does the company insist upon for agreement law?
Table of Contents
Executive SummaryChapter 1 - Introduction
Chapter 2 - Trends in co-development dealmaking
Chapter 3 - Overview of co-development deal structure
Chapter 4 - Leading co-development deals
Chapter 5 - Top 25 most active co-development dealmakers
Chapter 6 - Co-development deals including contracts directory
Deal directory
List of Figures
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- 1ST Biotherapeutics
- 2seventy bio
- 3B Pharmaceuticals
- 3DMed
- 3D Systems
- 4basebio Discovery
- 4D Molecular Therapeutics
- 10X Genomics
- A2A Pharmaceuticals
- Abbisko Therapeutics
- Abbott Laboratories
- Abbvie
- AbCellera Biologics
- AbelZeta Pharma
- Abingworth Life Sciences
- ABL Bio
- Abpro
- AbTherx
- AbVacc
- ABVC BioPharma
- Abzena
- ACADIA Pharmaceuticals
- Acceleron Pharma
- Accellix
- Accent Therapeutics
- Accord Healthcare
- ACEA Biosciences
- Ache
- AC Immune
- Acrivon Therapeutics
- Acuitas Therapeutics
- Adaptimmune
- Aduro BioTech
- Advaxis
- Affibody
- Affini-T Therapeutics
- AFT Pharmaceuticals
- AGC Biologics
- Agena Bioscience
- Agendia
- Agilent Technologies
- Agios Pharmaceuticals
- Aignostics
- AIkido Pharma
- AimedBio
- Ainos
- Ajinomoto
- Akcea Therapeutics
- Akoya Biosciences
- Akston Biosciences
- Albany Molecular Research
- Aldevron
- Alector
- Alexion Pharmaceuticals
- Algenex
- Aliada Therapeutics
- Alkem Laboratories
- Allele Biotechnology and Pharmaceuticals
- Alligator Bioscience
- Alnylam Pharmaceuticals
- Alphamab Biopharmaceuticals
- Alteogen
- Alternavida
- Altor BioScience
- Altos Group
- Alvotech
- Alytas Therapeutics
- Alzheimer's Drug Discovery Foundation
- Amerimmune
- Amgen
- Amyris
- Analog Devices
- Anavex Life Sciences
- AnchorDx
- AnGes MG
- AnHeart Therapeutics
- Anixa Biosciences
- Ankarys Therapeutics
- Apellis Pharmaceuticals
- Apmonia Therapeutics
- Apobiologix
- Apollomics
- Applied DNA Sciences
- Applied StemCell
- Aprecia Pharmaceuticals
- Aptar Pharma
- Aptevo Therapeutics
- Aquestive Therapeutics
- Arbele
- Arbor Biotechnologies
- Arcellx
- Arcturus Therapeutics
- Arcus Biosciences
- Ardeagen
- Arecor
- Argonaut Manufacturing Services
- Armatus Bio
- Arrowhead Pharmaceuticals
- ARTBIO
- Artes Biotechnology
- Artios Pharma
- Arvinas
- Asahi Kasei
- Ascenion
- Ascensia Diabetes Care
- Ascentage Pharma
- ASC Therapeutics
- ASKA Pharmaceuticals
- Aspect Biosystems
- Astellas Pharma
- AstraZeneca
- Athena Pharmaceutiques
- Atomwise
- Atropos Therapeutics
- Augmenta
- AUM Biosciences
- Aurealis Therapeutics
- Autotelic BIO
- Avacta
- Avactis Biosciences
- Avalon GloboCare
- Avellino Labs
- Avicanna
- Aviragen Therapeutics
- AXIM Biotechnologies
- Axolabs
- Azitra
- Azos Bio
- Bach Biosciences
- Banyan Biomarkers
- Bayer
- Beam Therapeutics
- BehaVR
- BeiGene
- Beijing Defengrei Biotechnology
- Beijing Sun-Novo Pharmaceutical Research
- Belharra Therapeutics
- Berry Genomics
- Betta Pharmaceuticals
- Beyondspring Pharmaceuticals
- Bharat Biotech
- Bill and Melinda Gates Foundation
- Bio-Rad Laboratories
- Bio-Techne
- BioAtla
- BioCardia
- BioComo
- BiocurePharm
- Biocytogen
- Biodesix
- Biodextris
- Bioelectronica
- BioGemex
- Biogen
- BIOHM Health Inc
- BioInvent
- BioKey
- BioLabs
- BioLegend
- BioMotiv
- Biomunex Pharmaceuticals
- BioNano Genomics
- BioNova Pharmaceuticals
- Bionpharma
- BioNTech
- BioNxt Solutions
- BiosanaPharma
- BioSerenity
- BioSun Pharmed
- BioVaxys
- BioVectra
- Bioventus
- BioVersys
- Blake Insomnia Therapeutics
- Blau Pharma
- Blood Centers of America
- Bloomios
- Blueberries Medical
- Bluebird Bio
- Blueprint Medicines
- Blue Water Vaccines
- BodyLogicMD
- Boehringer Ingelheim
- Bolt Biotherapeutics
- Boryung Pharmaceutical
- BrickBio
- BridgeBio Pharma
- Bridge Biotherapeutics
- Brigham and Women's Hospital
- BrighGene Biomedical
- Bristol-Myers Squibb
- Burning Rock
- Cadila Pharmaceuticals
- California Institute for Biomedical Research
- Cambrooke Therapeutics
- Can-Fite BioPharma
- Cancer Genetics
- CannaSoul Analytics
- Cannassure Therapeutics
- Capsida Biotherapeutics
- Captor Therapeutics
- Caraway Therapeutics
- CARB-X
- Carina Biotech
- Carl Zeiss Meditec
- Catalent
- CBT Pharmaceuticals
- Cedars-Sinai Medical Center
- Celgene
- Cellastra
- Cellgen Diagnostics
- Celltrion
- Cellular Biomedicine
- Cellvera
- Censa Pharmaceuticals
- Centre for Commercialization of Regenerative Medicine (CCRM)
- Cerenis Therapeutics
- Cerulean Pharma
- Champions Oncology
- Cheil Pharm
- ChemDiv
- Chi-Med
- Chiesi Global Rare Diseases
- China National Biotech Group (CNBG)
- Chinese Academy of Sciences
- Chiome Bioscience
- CicloMed
- Cidara Therapeutics
- CimCure
- Cipla
- Ciron Drugs & Pharmaceuticals
- Cleveland Clinic
- Closed Loop Medicine
- Coave Therapeutics
- Codagenix
- Coeptis Pharmaceuticals
- Coherus Biosciences
- Collplant
- Complement Pharma
- Confo Therapeutics
- Context Therapeutics
- Contineum Therapeutics
- Cosmo Pharmaceuticals
- CRISPR Therapeutics
- CrystalGenomics
- CSL
- CStone Pharmaceuticals
- CtM Biotech
- Cue Biopharma
- Cullgen
- Cullinan Oncology
- CURE Pharmaceutical
- CureVac
- Cyagen Biosciences
- Cygnus
- CytomX Therapeutics
- Dabur
- Daewoong Pharmaceutical
- Daiichi Sankyo
- Dana-Farber Cancer Institute
- Dance Biopharm
- DaRui Biotech
- Debiopharm
- Denali Therapeutics
- Densitas
- Department of Defense
- Department of Health and Human Services
- DePuy
- Dermavant Sciences
- Dicerna Pharmaceuticals
- DigiLab
- DotBio
- Dr. Falk Pharma
- Dryworld
- DSM
- DualityBio
- Duke-NUS Graduate Medical School Singapore
- Duoning Biotechnology
- Dyadic International
- Editas Medicine
- Eikon Therapeutics
- EirGenix
- Eisai
- Elektrofi
- ElevateBio
- EligoChem
- Eli Lilly
- Elite Pharmaceuticals
- Elpis Biomed
- Emergent BioSolutions
- Emmaus Life Sciences
- Empirico
- Energesis Pharmaceuticals
- Enigma Biomedical
- Ensysce Biosciences
- Entasis Therapeutics
- Enterome Bioscience
- EpiVax Therapeutics
- Especificos Stendhal
- EspeRare Foundation
- Esperovax
- Essex Bio-Technology
- Estee Lauder
- Evidation Health
- Evonetix
- Evotec
- EVQLV
- Evvivax
- Exact Sciences
- Eybna Technologies
- Eyegene
- Eyenovia
- Fabric Genomics
- FairJourney Biologics
- Fannin
- Farmacore Biotechnology
- Fate Therapeutics
- Fermbox Bio
- Ferrer
- Ferrer International
- FineImmune Biotechnology
- Firebrand Therapeutics
- Flightpath Biosciences
- Flowerkist
- Foghorn Therapeutics
- FogPharma
- Foresee Pharmaceuticals
- Formation Bio
- Formosa Pharmaceuticals
- Forsyth Institute
- Fosun Pharmaceutical
- Foundation Medicine
- Fresenius Kabi Pharmaceuticals
- Frontier Medicines
- Fulcrum Therapeutics
- Fusion Pharmaceuticals
- Fuzionaire Radioisotope Technologies
- Galapagos
- Galderma
- GB Sciences
- Gedeon Richter
- GE Healthcare
- Genentech
- GeneQuantum Healthcare
- Generate Biomedicines
- Genethon
- Geninus
- Genmab
- Genome Institute of Singapore
- Genomic Testing Cooperative
- Genoptix
- GenScript Biotech
- Genzyme
- Georgia State University Research Foundation (GSURF)
- Gicell
- GigaMune
- Gilead Sciences
- Ginkgo BioWorks
- Glatt Group
- Glimpse Group
- Global Antibiotic Research and Development Partnership
- Global Dx
- Glytherix
- GMSbiotech
- GoodRx
- GPCR Therapeutics
- Great Bay Bio
- Greenlight Biosciences
- GSK
- GTEC Holdings
- Guangzhou Boji Medical Biotechnological
- H3 Biomedicine
- HaloVax
- Hamlet Pharma
- HanAll Pharmaceuticals
- HanchorBio
- Hanmi Pharmaceutical
- Happify Health
- Harbour Biomed
- Harvard University
- HDT Bio
- HebeCell
- HEC Pharm
- Helsinn Healthcare
- Helsinn Therapeutics
- Henlius Biotech
- HiFiBio
- High Beauty
- Hikma Pharmaceuticals
- Histogen
- Hitachi Chemical
- HK inno.N
- HMNC Brain Health
- Hollister Biosciences
- Horizon Discovery
- Hoth Therapeutics
- HTC ChemRar
- Hummingbird Bioscience
- Hyloris Pharmaceuticals
- Hypospray Pharma
- I-mab
- i2c Pharmaceutical Services
- IACTA Pharmaceuticals
- iBio
- IBM Watson Health
- iCAD
- Icagen
- Idorsia
- Iktos
- Illumina
- Immatics Biotechnologies
- ImmBio
- ImmunityBio
- Immunocore
- IMPACT Therapeutics
- Impression Healthcare
- Incyte
- Indivumed
- Infex Therapeutics
- InflaRx
- Innate Pharma
- Innovent Biologics
- Inovio Pharmaceuticals
- Insilico Medicine
- Insitro
- InSitu Biologics
- Inspirna
- Institut Gustave Roussy
- Institut Pasteur
- Integrated Cannabis Company
- IntelGenx
- Intellia Therapeutics
- International Flavors and Fragrances
- Intravacc
- InventisBio
- inviCRO
- Ionis Pharmaceuticals
- iPharma
- Ipsen
- IRLAB
- Ironwood Pharmaceuticals
- iTeos Therapeutics
- iTolerance
- Ix Therapeutics
- Jabez Pharma
- Jacobio Pharmaceuticals
- Janssen Biotech
- Janssen Pharmaceuticals
- Janssen Pharmaceutica NV
- Janssen Research & Development
- Japan Tobacco
- JCR Pharmaceuticals
- Jeffrey Modell Foundation
- JelloX Biotech
- Jiangsu Carephar Pharmaceutical
- Jiangsu Hengrui Medicine
- Jiangsu NHWA Pharmaceutical
- Johns Hopkins University
- Johnson & Johnson Innovation
- JSR
- Junshi Biosciences
- JW Therapeutics
- Kadimastem
- Kaiku Health
- Kainos Medicines
- Kaken Pharmaceutical
- Kalos Therapeutics
- Kanabo Research
- Kartos Therapeutics
- Kite Pharma
- Klaria
- Kleo Pharmaceuticals
- KSQ Therapeutics
- Kudo Biotechnology
- Kyorin Pharmaceutical
- Kyowa Hakko Kirin
- Kyverna Therapeutics
- Laboratoires Thea
- Laboratorios Ordesa
- Laekna
- Lannett
- Launch Therapeutics
- Laxai Pharma
- Lead Discovery Center
- Legend Biotech
- LegoChem Biosciences
- Leon-nanodrugs
- LEO Pharma
- Les Laboratoires Servier
- Leucid Bio
- Leukemia & Lymphoma Society
- LG Life Sciences
- LianBio
- LifeLink Foundation
- LifeLiver
- Life Magnetics
- LineaRx
- Lipidor
- Lipigon Pharmaceuticals
- Livzon Pharmaceutical
- Louisiana State University
- Loxo Oncology
- LTS Lohmann Therapie-Systeme
- Lumen Biomedical
- Lundbeck
- Luye Pharma Group
- Lyell Immunopharma
- Lygos
- Magic Leap
- MAKScientific
- MangoGen Pharma
- Marizyme
- MASORI Therapeutic
- Massachusetts General Hospital
- MaSTherCell
- Max-Delbruck Center for Molecular Medicine
- Maxcyte
- Mayo Clinic
- McQuade Center for Strategic Research and Development
- MD Anderson Cancer Center
- Meatable
- Mechelen
- Medicines Discovery Catapult
- MediciNova
- Medigen Biotechnology
- Medigen Vaccine Biologics
- MedImmune
- MedinCell
- Medocann Pharma
- Medolife Rx
- Medtronic
- Medytox
- MEI Pharma
- Melinta Therapeutics
- Memorial Sloan Kettering Cancer Center
- Menarini
- Mercachem
- Merck and Co
- Merck KGaA
- Merdury Biopharmaceutical
- Meridian Laboratories
- Mersana Therapeutics
- Merus
- Merz
- Mesoblast
- Metagenomi
- Metalabs
- MetP Pharma
- Microbiotix
- Mie University
- MiLaboratories
- Millennium
- Miltenyi Biotec
- Mirati Therapeutics
- Mission Bio
- Mission Health
- Mochida Pharmaceutical
- Moderna
- Molecular Partners
- Molecular Templates
- Mologen
- Momenta Pharmaceuticals
- Morphic Therapeutic
- MorphoSys
- Mount Sinai Medical Center
- MSD Wellcome Trust Hilleman Laboratories
- Mundipharma
- Mundo Sano
- Mydecine Group
- MYOS
- Myriad Genetics
- Nanion
- Nanobiotix
- Nanoform
- NanoSmart Pharmaceuticals
- NantKwest
- Nascent Biotech
- NATA
- National Cancer Institute
- National Immunobiological Company
- National Institutes of Health
- Navitor Pharmaceuticals
- Ncardia
- NEC
- NEC Bio Therapeutics
- Nektar Therapeutics
- Neo Gene Pharm
- Neptune Technologies & Bioressources
- Neptune Wellness Solutions
- Nestle Health Science
- Neuracle Genetics
- Neuraly
- Neuro3 Therapeutics
- Neurochase
- Neurocrine Biosciences
- Neurophth Therapeutics
- Newly Institute
- Newsoara Biopharma
- NextCure
- Next Generation Manufacturing Canada
- NFL Biosciences
- NGK Spark PLug
- Nipro Corporation
- Nivagen Pharmaceuticals
- Nkarta Therapeutics
- Noile-Immune Biotech
- Noramco
- Northern RNA
- Notable Labs
- NOTA Laboratories
- Novartis
- Novavax
- Novel351k
- NovImmune
- Novoheart
- Novo Nordisk
- Nuance Pharma
- Numab
- Nurix Therapeutics
- NurrOn Pharmaceuticals
- NutriQuest
- Ocean Genomics
- Ocugen
- Ocumension Therapeutics
- OmniaBio
- OncoC4
- Oncologie
- Oncology Pharma
- Oncology Venture
- Oncozen
- OncoZenge
- One BioMed
- ONK Therapeutics
- Ono Pharmaceutical
- Onward Therapeutics
- OpenAI
- Open Book Extracts
- OPKO Health
- Optimi Health
- Optum
- Orano Med
- Ordaos Bio
- Orgenesis
- Ori Biotech
- Orient Pharma
- Orion
- Orizuru Therapeutics
- Osaka University
- OSE Immunotherapeutics
- Otsuka
- Oxford BioMedica
- Oxis International
- P-Chip
- PACT Pharma
- Paige
- Palisade Bio
- Pall Corporation
- Partex Group
- Pasithea Therapeutics
- Pathalys Pharma
- PDS Biotechnology
- PeptiDream
- PeptiGrowth
- Perlara
- Persist AI
- Pfizer
- Pharmanovia
- PhaseBio Pharmaceuticals
- Phillips-Medisize
- Phlow
- PhoreMost
- Photocure ASA
- Pieris Pharmaceuticals
- Pierre Fabre
- Pleco Therapeutics
- Plexium
- PMV Pharma
- Polyphor
- Portal Bioscience
- Precise Biometrics
- Precisio Biotix Therapeutics
- PrecisionLife
- Precision NanoSystems
- Predicine
- Prelude Therapeutics
- Premier Inc
- Prestige BioPharma
- Prevail Therapeutics
- PreventionGenetics
- Primrose Bio
- PRISM BioLab
- Procare Health
- ProGen Co
- Project to Accelerate New Treatments for Tuberculosis
- Proliant Health and Biologicals
- Promethera Biosciences
- Prometheus Biosciences
- Promore Pharma
- Propeller Health
- Protagonist Therapeutics
- Protein Sciences
- Proteovant Therapeutics
- Provention Bio
- Psyence Biomedical
- Pulmatrix
- Purdue Pharma
- Purdue University
- Pure Extracts Technologies
- Pure Protein
- QED Therapeutics
- Qiagen
- Qilu Pharmaceutical
- Quadira Biosciences
- Qualigen
- Quark Pharmaceuticals
- Quell Therapeutics
- Quratis
- Rad AI
- Rainbow Medical
- Rakuten Medical
- Rambam Medical Center
- Ramot at Tel Aviv University
- Rani Therapeutics
- Rebus Biosystems
- RedHill Biopharma
- RefleXion Medical
- Refuge Biotechnologies
- Regen BioPharma
- Regeneron Pharmaceuticals
- RemeGen
- Repare Therapeutics
- Replicel Life Sciences
- RespireRx Pharmaceuticals
- Retrophin
- ReveraGen BioPharma
- Reyon Pharmaceuticals
- Rgene
- Richard Wolf Medical Instruments
- Rigel Pharmaceuticals
- Roche
- Roche Diagnostics
- Rocket VR Health
- RoosterBio
- Rosalind
- Royal Philips Electronics
- Rznomics
- Sajo Consulting
- Salus Pharma
- Samsung Biologics
- Sandoz
- SanegeneBio
- Sanofi
- Santen Pharmaceutical
- Sarepta Therapeutics
- SATT Nord
- SATT Paris-Saclay
- Scandinavian Health
- Scandion Oncology
- Schrodinger
- SciClone Pharmaceuticals
- SCM Pharma
- Scorpion Therapeutics
- Scottish Enterprise
- Scribe Therapeutics
- Seagen
- Seattle Genetics
- Secarna Pharmaceuticals
- Seikagaku
- Seipasa
- Selvita
- Sen-Jam Pharmaceutical
- Senai Cimatec
- Sensorion
- Sentieon
- Sentinel Oncology
- SequMed
- Serum Institute of India
- SFJ Pharmaceuticals
- SGN Nanopharma
- Shandong Boan Biological Technology
- Shandong Luoxin Pharma
- Shanghai Ark Biopharmaceutical
- Shanghai Institute of Materia Medica
- Sheba Medical Center
- Shimadzu
- Siemens Healthineers
- SimBioSys
- Simcere Pharmaceuticals
- Similis Bio
- Sinergium Biotech
- Sirenas
- Siren Biotechnology
- Sirnaomics
- SiSaf
- SK Bioscience
- SK Pharmteco
- SN BioScience
- Sofregen Medical
- Solid Biosciences
- Sonova
- Sorrento Therapeutics
- Sosei
- Spectrum Pharmaceuticals
- Spencer Health Solutions
- Spruce Biosciences
- STADA Arzneimittel
- Staidson (Beijing) BioPharmaceuticals
- Stealth BioTherapeutics
- StemCardia
- StemoniX
- Stempeutics
- Stockton Group
- Stoke Therapeutics
- StrideBio
- SUDA Pharmaceuticals
- Sumitomo Dainippon Pharma
- SunGen
- Sunny Pharmtech
- Sunovion Pharmaceuticals
- Supernus Pharmaceuticals
- Sutro Biopharma
- Swedish Orphan Biovitrum
- Symbasis
- Synpromics
- Tachyon Therapeutics
- Tactical Relief
- Taiho
- TaiwanBio Therapeutics
- TaiwanJ Pharmaceuticals
- Takeda Pharmaceutical
- Takis Biotech
- TALLC
- Tango Therapeutics
- Tarveda Therapeutics
- Tavotek Biotherapeutics
- TC BioPharm
- Teijin
- Telix Pharmaceuticals
- Tetra Bio-Pharma
- Teva Pharmaceutical Industries
- Texas A&M University
- TFF Pharmaceuticals
- TG Therapeutics
- The Jackson Laboratory
- The Nutraceutical Medicine Company
- Therapyx
- Theravance
- Thermo Fisher Scientific
- Tianjin CanSino Biotechnology
- Tilray
- TOMA Biosciences
- Torii Pharmaceutical
- Torrey Pines Investment
- Transcenta
- TransCode Therapeutics
- Transgene
- Transplant Genomics
- Treventis
- Trovita Health Science
- TRPharm
- Turnstone Biologics
- Twist Bioscience
- TYG Oncology
- UbiQ
- Ubiquigent
- UCB
- UGISense
- Ultragenyx Pharmaceuticals
- Uni-Bio Science
- United Therapeutics
- Univercells
- Universal Cells
- University of Bonn
- University of Copenhagen
- University of Heidelberg
- University of Massachusetts Medical School
- University of North Texas
- Univo Pharmaceuticals
- Vaccitech
- Valent Biosciences
- Valneva
- Vasomune Therapeutics
- Vaximm
- Vaxine
- Vaxxas
- VectorBuilder
- Velabs Therapeutics
- VenatoRx
- Ventana Medical Systems
- Veranome Biosystems
- Veraxa Biotech
- Verge Genomics
- Vertex Pharmaceuticals
- ViaCyte
- Vical
- Vici Health Sciences
- Vifor-Fresenius Medical Care Renal Pharma
- Vir Biotechnology
- Virginia Tech
- vivoPharm
- Volta Medical
- Voltron Therapeutics
- Voluntis
- Voyager Therapeutics
- Vyant Bio
- VyGen-Bio
- Wanchunbulin
- WAVE Life Sciences
- Weill Cornell Medical College
- WellDoc
- Wellmarker Bio
- Westlake Pharma
- Willow Biosciences
- W L Gore
- WuXi Biologics
- Wyss Institute
- X4 Pharmaceuticals
- Xbiome
- Xbrane Bioscience
- Xencor
- Xenon Pharmaceuticals
- XERIS Pharmaceuticals
- Xortx Therapeutics
- Xylonix
- Yabao Pharmaceutical
- Yatiri Bio
- Yingli Pharma
- Yisheng Biopharma
- YOFOTO (China) Health Industry
- Yonsei University Severance Hospital
- Yuhan Corporation
- Yunnan Walvax Biotech
- YVY Life Sciences
- ZAI Laboratory
- Zealand Pharma
- Zivo Bioscience
- Zylo Therapeutics
Methodology
- The publisher reports provide insight into the trends and terms of partnering deals in the global life sciences sector.
- The publisher reports are updated every six months to ensure the user has access to the latest announcements and trends in the topic focus of the report.
- The publisher analysts review the deal data to provide an overview and analysis of deal trends, including example deals and terms.
- The publisher reports source deal data from our proprietary deals and alliances database. The database is updated daily by our analysts with new deals as they are announced globally by the company’s party to the deal.
- The data in the deals and alliances database is obtained from secondary sources such as publicly available industry sources including press releases, company presentations, investor presentations, company SEC filings, other company filings, company websites, conference presentations. Sources are identified to allow for user verification.
The publisher provides comprehensive coverage of the following partnering or deal types:
- Asset purchase
- Assignment
- Co-development
- Co-market
- Co-promotion
- Collaborative R&D
- Contract service
- CRADA
- Cross-licensing
- Development
- Distribution
- Equity purchase
- Evaluation
- Grant
- Joint venture
- Licensing
- Loan
- Manufacturing
- Marketing
- Option
- Promotion
- Research
- Royalty financing
- Settlement
- Spin out
- Sub license
- Supply
- Termination
- Warrant
Every deal record is fully categorized and includes the following data, where available:
- Industry sector
- Therapy areas
- Technology type
- Deal components
- Financial terms
- Stage of development
- Exclusivity
- Asset type
- Geographic focus
- Excluded geography
- Company press release
- SEC filing data including contract document
All financial amounts are converted to US$ using the exchange rate available on the date of deal announcement, enabling direct comparison of deal terms across international territories.
LOADING...
